Crucial conceptual concepts in the evaluation and management of advanced basal cell carcinoma
- PMID: 36244552
- DOI: 10.1016/j.jaad.2022.07.066
Crucial conceptual concepts in the evaluation and management of advanced basal cell carcinoma
Keywords: Hedgehog; aberration; advanced; basal; burden; carcinoma; cell; cemiplimab; check; death-ligand; dermatology; gene; genomic; immunohistochemistry; immunotherapy; inhibitor; medicine; metastatic; molecular; mutational; next; nivolumab; oncology; pembrolizumab; point; precision; programmed; sequencing; sonidegib; tumor; vismodegib.
Conflict of interest statement
Conflicts of interest Philip R. Cohen is a consultant for ParaPRO. However, the consultantship did not influence the work reported in this paper. Dr Kurzrock receives research funding from Genentech, Merck Serono, Pfizer, Boehringer Ingelheim, TopAlliance, Takeda, Incyte, Debiopharm, Medimmune, Sequenom, Foundation Medicine, Konica Minolta, Grifols, Omniseq, and Guardant, as well as consultant and/or speaker fees and/or advisory board for X-Biotech, Neomed, Pfizer, Actuate Therapeutics, and Roche has an equity interest in IDbyDNA and CureMatch Inc, serves on the Board of CureMatch and CureMetrix, and is a co-founder of CureMatch.
Comment in
-
Advanced basal cell carcinoma: What dermatologists need to know about treatment.J Am Acad Dermatol. 2023 Jan;88(1):e63. doi: 10.1016/j.jaad.2022.10.013. Epub 2022 Oct 13. J Am Acad Dermatol. 2023. PMID: 36244555 No abstract available.
Comment on
-
Advanced basal cell carcinoma: What dermatologists need to know about diagnosis.J Am Acad Dermatol. 2022 Jun;86(6S):S1-S13. doi: 10.1016/j.jaad.2022.03.023. J Am Acad Dermatol. 2022. PMID: 35577405 Review.
-
Advanced basal cell carcinoma: What dermatologists need to know about treatment.J Am Acad Dermatol. 2022 Jun;86(6S):S14-S24. doi: 10.1016/j.jaad.2022.03.022. J Am Acad Dermatol. 2022. PMID: 35577406 Review.
Similar articles
-
Advanced basal cell carcinoma: What dermatologists need to know about treatment.J Am Acad Dermatol. 2023 Jan;88(1):e63. doi: 10.1016/j.jaad.2022.10.013. Epub 2022 Oct 13. J Am Acad Dermatol. 2023. PMID: 36244555 No abstract available.
-
Advanced basal cell carcinoma: What dermatologists need to know about treatment.J Am Acad Dermatol. 2022 Jun;86(6S):S14-S24. doi: 10.1016/j.jaad.2022.03.022. J Am Acad Dermatol. 2022. PMID: 35577406 Review.
-
Hedgehog Pathway Inhibition.Cell. 2016 Feb 25;164(5):831. doi: 10.1016/j.cell.2016.02.021. Cell. 2016. PMID: 26919418
-
Vismodegib: a guide to its use in locally advanced or metastatic basal cell carcinoma.Am J Clin Dermatol. 2013 Feb;14(1):61-4. doi: 10.1007/s40257-012-0004-6. Am J Clin Dermatol. 2013. PMID: 23329081
-
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature.Chemotherapy. 2020;65(1-2):2-10. doi: 10.1159/000509156. Epub 2020 Aug 10. Chemotherapy. 2020. PMID: 32777789 Review.
Cited by
-
Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma.NPJ Precis Oncol. 2025 Jan 24;9(1):24. doi: 10.1038/s41698-024-00798-1. NPJ Precis Oncol. 2025. PMID: 39856213 Free PMC article.
-
Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions-Precision Dermatology.Dermatol Ther (Heidelb). 2022 Oct;12(10):2249-2271. doi: 10.1007/s13555-022-00801-2. Epub 2022 Sep 19. Dermatol Ther (Heidelb). 2022. PMID: 36121579 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
